Mettler-Toledo InternationalFRA:MTO -2.67%92 3-Year ROIIC % is 4.68 as of Dec. 2025, which is 89% below its 10-year median of 42.28. GuruFocus rates FRA:MTO with a GF Score™ of 92/100 and a GF Value™ of €1,240.22 (Fairly Valued). The stock has 1 warning sign investors should review. Among 203 Medical Diagnostics & Research companies, Mettler-Toledo International ranks better than 52.71% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Mettler-Toledo International's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 4.68%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
FRA:MTO's 3-Year ROIIC % is ranked better than 52.71% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22
vs FRA:MTO: 4.68
Mettler-Toledo International (FRA:MTO) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Mettler-Toledo International 3-Year ROIIC % Related Terms
Mettler-Toledo International 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MTO vs ILMN, DGX, LH: 3-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Mettler-Toledo International's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International 3-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Mettler-Toledo International (FRA:MTO) has a 3-Year ROIIC % of 4.68 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mettler-Toledo International and its competitors. This is 89% below median its historical median of 42.28. According to the industry distribution chart, Mettler-Toledo International ranks #96 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 47.3%.
Is Mettler-Toledo International's 3-Year ROIIC % too high?
Mettler-Toledo International's current 3-Year ROIIC % of 4.68 is 89% below median its 10-year median of 42.28. The Medical Diagnostics & Research industry median 3-Year ROIIC % is 0.22. Mettler-Toledo International's value of 4.68 is 2027.3% above this industry median. Based on the distribution chart, Mettler-Toledo International ranks #96 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's 3-Year ROIIC % compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #96 out of 203 companies for 3-Year ROIIC %. This puts Mettler-Toledo International in the upper half of its industry. The industry median 3-Year ROIIC % is 0.22. Mettler-Toledo International's value of 4.68 is 2027.3% above this benchmark. While the company's 10-year median is 42.28 vs. the industry median of 0.22, Mettler-Toledo International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Diagnostics & Research company?
The median 3-Year ROIIC % among Medical Diagnostics & Research companies is 0.22, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mettler-Toledo International's current 3-Year ROIIC % of 4.68 is 2027.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year ROIIC % is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current 3-Year ROIIC % is 4.68, which is 89% below median its own 10-year median of 42.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (FRA:MTO) is currently considered Fairly Valued. The stock's GF Value™ is €1,240.22, compared to a current price of €1,129.00 — trading 9% below its estimated fair value. The current 3-Year ROIIC % is 4.68, which is 89% below median its 10-year median of 42.28 and 2027.3% above the Medical Diagnostics & Research industry median of 0.22. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current 3-Year ROIIC % is 4.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,129.00 is trading 9% below its estimated GF Value™ of €1,240.22.
GuruFocus considers Mettler-Toledo International to be Fairly Valued.
Key valuation signals for FRA:MTO:
3-Year ROIIC %: 4.68 (89% below median its 10-year median of 42.28)
GF Value™: €1,240.22 vs. price of €1,129.00 (9% below fair value)
Industry Position: 2027.3% above the Medical Diagnostics & Research median (#96 of 203)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
